TherapeuticsMD, Inc.
corporate_fare Company Profile
TherapeuticsMD, Inc. (NASDAQ:TXMD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 8 items for TXMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-11, rated 7/10. Across its 8 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for TXMD spans 10-Q, 8-K.
Recent high-impact activity:
- TherapeuticsMD Q2 License Revenue Falls; Strategic Review Continues
- TherapeuticsMD Q2 Net Income Drops to $155K; Going Concern Warning Reiterated
- TherapeuticsMD Reports Q2 2026 Results: Net Income Falls to $164K, Cash at $9.2M, Strategic Alternatives Under Review
- TherapeuticsMD Reports Q1 Profit and Increased Cash, but Discloses Substantial Doubt About Going Concern
- TherapeuticsMD Explores Sale or Merger After Swinging to Q1 Net Income
Financial Snapshot
Short Interest & Short Volume
1.27 days to coverFINRA reported short interest of 26,437 shares in TXMD as of the September 15, 2026 settlement, a 0.2% increase from the prior period — about 1.3 days to cover at its recent average daily volume. On October 2, 2026, 18.4% of TXMD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.